EPTRI is honored to announce its Giovanni Migliaccio’s nomination to represent the research stakeholder group within the TRANSFORM Steering Group.
EPTRI will contribute with its pivotal knowledge by representing the academic research perspective. EPTRI will support the project in its dissemination actions and, at the same time, will promote its goals within the European and international health ecosystem to improving equitable access to the most innovative medicines, such as ATMPs.
As member of the TRANSFORM Steering Group, EPTRI will be involved in:
– Taking decisions about its strategic direction, including review of activities and preparation of annual work plans
– Lending leadership and guidance in delivering its vision, mission, goals and strategy
– Representing it at external events and ensuring to consistently talk with one voice in promoting TRANSFORM’s recommendations.